DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,930,000 | -49.2% | 393,390 | -5.9% | 0.05% | -49.5% |
| Q2 2021 | $15,609,000 | -47.6% | 418,245 | -70.3% | 0.11% | -56.9% |
| Q1 2021 | $29,816,000 | -3.9% | 1,408,993 | 0.0% | 0.25% | +0.8% |
| Q4 2020 | $31,041,000 | +42.7% | 1,408,993 | +16.5% | 0.25% | +20.6% |
| Q3 2020 | $21,753,000 | -36.2% | 1,209,206 | -10.0% | 0.20% | -43.3% |
| Q2 2020 | $34,121,000 | +80.2% | 1,343,269 | +52.7% | 0.36% | +71.4% |
| Q1 2020 | $18,940,000 | -2.2% | 879,500 | 0.0% | 0.21% | +1.0% |
| Q4 2019 | $19,375,000 | +87.5% | 879,500 | +22.2% | 0.21% | +51.8% |
| Q3 2019 | $10,332,000 | +4.8% | 719,500 | +50.0% | 0.14% | +11.4% |
| Q2 2019 | $9,860,000 | +50.4% | 479,800 | +7.2% | 0.12% | +46.4% |
| Q1 2019 | $6,556,000 | +37.0% | 447,500 | 0.0% | 0.08% | +13.5% |
| Q4 2018 | $4,784,000 | +7.6% | 447,500 | +53.5% | 0.07% | +25.4% |
| Q3 2018 | $4,448,000 | +203.6% | 291,500 | +177.6% | 0.06% | +96.7% |
| Q2 2015 | $1,465,000 | -58.0% | 105,000 | -27.6% | 0.03% | -57.1% |
| Q1 2015 | $3,485,000 | +92.3% | 145,000 | +31.8% | 0.07% | +84.2% |
| Q4 2014 | $1,812,000 | – | 110,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|